Tyrosine kinase 3D structures
From Proteopedia
(Difference between revisions)
| Line 487: | Line 487: | ||
*'''ErbB tyrosine kinase''' see [[Epidermal Growth Factor Receptor]] | *'''ErbB tyrosine kinase''' see [[Epidermal Growth Factor Receptor]] | ||
| - | *'''MuSK tyrosine kinase''' | + | *'''MuSK tyrosine kinase''' or '''muscle skeleton receptor tyrosine kinase''' |
**[[3hkl]] - rTK MuSK Fz-Crd domain <br /> | **[[3hkl]] - rTK MuSK Fz-Crd domain <br /> | ||
| Line 496: | Line 496: | ||
**[[5ve6]] - hTK <br /> | **[[5ve6]] - hTK <br /> | ||
| - | *'''Matk tyrosine kinase''' or megakaryocyte-associated tyrosine-protein kinase | + | *'''Matk tyrosine kinase''' or '''megakaryocyte-associated tyrosine-protein kinase''' |
**[[3us4]] - hTK Matk SH2 domain <br /> | **[[3us4]] - hTK Matk SH2 domain <br /> | ||
| - | *'''Cbl-c tyrosine kinase''' | + | *'''Cbl-c tyrosine kinase''' or '''signal transduction protein Cbl-c''' |
| + | **[[3vrn]] - hTK Cbl-c kinase domain <br /> | ||
| + | **[[3vrq]] - hTK Cbl-c kinase domain (mutant)<br /> | ||
**[[3vro]] - hTK Cbl-c kinase domain + Src peptide<br /> | **[[3vro]] - hTK Cbl-c kinase domain + Src peptide<br /> | ||
**[[3vrp]] - hTK Cbl-c kinase domain + EGRF peptide<br /> | **[[3vrp]] - hTK Cbl-c kinase domain + EGRF peptide<br /> | ||
**[[3vrr]] - hTK Cbl-c kinase domain (mutant) + EGRF peptide<br /> | **[[3vrr]] - hTK Cbl-c kinase domain (mutant) + EGRF peptide<br /> | ||
| + | **[[3op0]] - hTK Cbl-c N-terminal domain (mutant) + EGRF peptide<br /> | ||
| - | *'''Flt3 tyrosine kinase''' | + | *'''Flt3 tyrosine kinase'''; Domains - kinase 564-958 |
**[[1rjb]] - hTK Flt3 kinase domain <br /> | **[[1rjb]] - hTK Flt3 kinase domain <br /> | ||
**[[4rt7]], [[6il3]], [[5x02]] - hTK Flt3 kinase domain + inhibitor<br /> | **[[4rt7]], [[6il3]], [[5x02]] - hTK Flt3 kinase domain + inhibitor<br /> | ||
**[[4xuf]], [[6jqr]] - hTK Flt3 kinase domain (mutant) + leukemia drug<br /> | **[[4xuf]], [[6jqr]] - hTK Flt3 kinase domain (mutant) + leukemia drug<br /> | ||
| + | **[[3qs9]], [[3qs7]] - hTK Flt3 residues 27-540 + SL cytokine <br /> | ||
*'''Tie2 tyrosine kinase''' | *'''Tie2 tyrosine kinase''' | ||
| Line 520: | Line 524: | ||
**[[6nja]] - hTK Ret kinase domain<br /> | **[[6nja]] - hTK Ret kinase domain<br /> | ||
**[[6fek]] - hTK Ret kinase domain (mutant)<br /> | **[[6fek]] - hTK Ret kinase domain (mutant)<br /> | ||
| - | **[[5amn]], [[6vhg]] - hTK Ret kinase domain + inhibitor<br /> | + | **[[2ivt]], [[2ivs]] - hTK Ret kinase domain + AMP<br /> |
| + | **[[4ckj]] - hTK Ret kinase domain + adenosine<br /> | ||
| + | **[[4cki]] - hTK Ret kinase domain (mutant) + adenosine<br /> | ||
| + | **[[5amn]], [[6vhg]], [[2ivv]], [[2ivu]], [[2x2k]], [[2x2l]], [[2x2m]] - hTK Ret kinase domain + inhibitor<br /> | ||
**[[6i83]], [[6i82]] - hTK Ret kinase domain (mutant) + inhibitor<br /> | **[[6i83]], [[6i82]] - hTK Ret kinase domain (mutant) + inhibitor<br /> | ||
**[[6nec]], [[6ne7]], [[7ju5]], [[7ju6]] - hTK Ret kinase domain + cancer drug<br /> | **[[6nec]], [[6ne7]], [[7ju5]], [[7ju6]] - hTK Ret kinase domain + cancer drug<br /> | ||
Revision as of 11:21, 29 December 2020
3D structures of tyrosine kinase
Updated on 29-December-2020 - For a general description of the protein see Tyrosine kinase
